Development
Zimmer Biomet Holdings, Inc.
ZBH
$92.38
$0.460.50%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 6.55% | 5.62% | 4.17% | 3.17% | 1.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.55% | 5.62% | 4.17% | 3.17% | 1.65% |
| Cost of Revenue | 3.18% | 1.45% | -0.20% | -0.19% | 3.01% |
| Gross Profit | 7.93% | 7.37% | 6.00% | 4.57% | 1.10% |
| SG&A Expenses | 6.12% | 5.92% | 3.39% | 2.27% | 0.21% |
| Depreciation & Amortization | 6.59% | 4.18% | 1.48% | 0.51% | -0.51% |
| Other Operating Expenses | -- | -73.11% | -57.61% | -44.51% | -35.98% |
| Total Operating Expenses | 4.96% | 4.18% | 2.10% | 0.08% | 0.23% |
| Operating Income | 13.28% | 11.92% | 13.26% | 17.75% | 8.14% |
| Income Before Tax | 164.51% | 79.51% | 63.51% | 52.58% | -19.14% |
| Income Tax Expenses | -62.42% | 740.43% | 120.11% | 129.14% | 109.91% |
| Earnings from Continuing Operations | 252.03% | 29.59% | 51.24% | 38.38% | -34.64% |
| Earnings from Discontinued Operations | -- | 100.00% | 100.00% | 100.00% | -35.48% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -10.00% | -12.50% | -12.50% | 9.09% | -100.00% |
| Net Income | 342.52% | 70.67% | 120.31% | 106.57% | -42.38% |
| EBIT | 13.28% | 11.92% | 13.26% | 17.75% | 8.14% |
| EBITDA | 8.93% | 7.26% | 7.51% | 9.46% | 4.08% |
| EPS Basic | 344.81% | 71.62% | 120.52% | 105.72% | -42.74% |
| Normalized Basic EPS | 33.83% | 5.90% | 10.04% | 16.77% | -6.52% |
| EPS Diluted | 345.75% | 71.61% | 121.53% | 108.36% | -42.34% |
| Normalized Diluted EPS | 33.53% | 5.67% | 10.07% | 17.07% | -6.11% |
| Average Basic Shares Outstanding | -0.43% | -0.10% | 0.13% | 0.37% | 0.49% |
| Average Diluted Shares Outstanding | -0.19% | 0.06% | 0.06% | 0.06% | 0.01% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.77% | -0.41% | -0.55% | -0.51% | 0.75% |